Now that the blogs have been nominated and placed into their respective categories, it is up to their readers to select the very best. The process allows participants one vote per blog. Each blog will compete for rank within its category, while the three blogs that receive the most votes in any category will be crowned overall winners.
The competition will run from August 27th until the close of voting at 12:00 AM on October 9th, at which point the votes will be tallied and the winners announced.
The competition can be found at https://www.theexpertinstitute.com/blog-contest/
The USPTO AIR form is available here.
This is the type of 21st Century Government we’ve all been longing for. You can fill out a very quick, simple form, propose a time and day for an interview with the examiner, digitally sign and you’re done. Beautiful!
If you have questions or need assistance with the USPTO AIR form or with interview practice at the USPTO, you may contact an Interview Specialist or send an email to ExaminerInterviewPractice@USPTO.GOV.]]>
In the letter, advocates argue that the Innovation Act does little to address current abuses in the Inter Partes Review (IPR) process that threaten the Drug Price Competition and Patent Term Restoration Act (the Hatch-Waxman Act) and the Biologics Price Competition and Innovation Act (BPCIA).
According to the letter:
The Inter Partes Review (IPR) proceedings were intended to be a more efficient way to address patent challenges, but IPR opened the door to abuses that threaten the unique and specialized mechanisms under the Drug Price Competition and Patent Term Restoration Act (commonly referred to as the Hatch-Waxman Act) and the Biologics Price Competition and Innovation Act (BPCIA). Congress established these carefully-crafted patent dispute resolution frameworks to balance the interests of innovators, generic and biosimilar manufacturers, and, most importantly, the individuals waiting for a treatment or cure. This system generally works well. Many generic medications are entering the market while, at the same time, innovative R&D is delivering new treatments to patients. These trends are helping individuals with chronic and complex conditions live longer, healthier lives.
The letter goes on to state:
Congress never intended for the IPR proceedings to undermine the patent dispute resolution frameworks in Hatch-Waxman and BPCIA. We urge Congress to include language in H.R. 9 that would preserve the highly-detailed and sophisticated systems designed by Hatch-Waxman and BPCIA to avoid weakening the patents that sustain medical research. Strong patents will ensure that innovative ideas make it from the lab to the people who need them most.
See the entire letter here.
A new film, tentatively entitled ‘TROLLS‘, is currently in pre-production and into fundraising on Indiegogo. Apparently, the film is a feature length comedy (comedy? really?) about start-ups, crowdfunding, and patent trolls.
Understandably, the working title of Patent Assertion Entities! was probably not such a great idea. Whether or not you believe that patent trolls are (quote) an ugly, stinky zit on the face of the American legal system (unquote), I have to applaud their moxie.
Filmmakers in Austin, TX are using crowdfunding to bring their new comedy film to life. ‘TROLLS’ will tell the story of one tech start-up that’s ruined by a patent troll, but figures out a creative way to fight back!
Lex Lybrand, the writer/director of the new feature comedy film, writes:
I wrote the script after months of research that included getting first-hand accounts from residents of Marshall, TX, stories from entrepreneurs that have been (or are still being) sued, and stories from the various podcasts that have been involved with trolls in the last few years. I’m hoping to shine a bright light on the ridiculousness of this whole industry with this film.
According to the press release:
Trolls tells the (fictional) story of a tech start-up in Austin, TX that invents an amazing new product — the NeverCharge Battery. Their device uses a combination of magnets & wireless charging to instantly bring any cell phone battery to a full charge… forever. Naturally, their invention takes the world by storm & they shatter every crowdfunding record. Everything is great until they’re served with a lawsuit by a patent troll. They lose everything when a shady judge in Marshall, TX uses an even shadier interpretation of an outdated intellectual property law to enforce a patent that the troll owns.
This sounds absurd, but it happens every day.
Trolls aims to bring this issue to an even wider audience, and Lybrand hopes his satirical profile of the industry will help move Congress in the right direction. “I can’t do anything about it, legally… But maybe if I make fun of it then somebody who can do something about it will do something about it.”
You can find out more and contribute to the Indiegogo campaign today at: http://www.indiegogo.com/at/TrollTheTrolls.
Here is the press release for the film: http://www.prlog.org/12465997-indie-comedy-film-trolls-takes-on-patent-trolls-via-indiegogo.html]]>
ADVISORY (13Jun2015) USPTO Announces Enhancements to Private PAIR
Beginning on June 13, 2015, users will notice several new Private PAIR features that will allow users to self-administer a number of routine administrative tasks that previously required the submission of a paper form. These requests will be processed immediately. The enhancements include the ability to submit entity status changes, create new customer numbers, submit correspondence and/or maintenance fee address changes, and view saved or submitted requests. The Address & Attorney/Agent tab has also been enhanced to include complete information for correspondence address, maintenance fee address and power of attorney information.
>> PAIR Administration FAQs
Entity Status Changes
>> Entity Status Change QSG
Create New Customer Number
>> Create New Customer Number QSG
Update Application Address
>> Update Application Address QSG
View Saved and Completed Requests
Address & Attorney/Agent tab